Vol 32 No 10

With a consistent and evolving presence in the US, forensic psychiatry has grown increasingly complex, with many specialty areas under its subspecialty umbrella.

Psychiatrists should not be afraid to assess parenting issues and other stressors when treating depressed or psychotic parents of young children.

About 25% of children in the US live with only one parent; the fallout from contentious divorces often leaves them susceptible to any number of damaging scenarios.

This article reviews a wide array of medicolegal, risk management, regulatory, and forensic mental health issues in the older population, which is growing at an accelerated rate.

Reporting of symptoms that are beyond available medical evidence is a central feature of malingering and related conditions, making the clinical differentiation of these disorders a challenge.

This article focuses primarily on the issues facing a psychiatrist who has been retained as an expert witness in a will or trust contest involving claims of a lack of capacity.

A report on substance abuse and HIV research around the world.

The effects of climate change are severe and global, affecting world economies, triggering migrations and wars, and having profound effects on mental and physical health.

The views of mental health experts on changes in psychiatric theory and practice since World War II.

An update on what happens in the brain when the mind is engaged in psychotherapy.

The Editor in Chief of Psychiatric Times discusses some of our new initiatives to bring readers the most up-to-date information in the field of psychiatry.

The clinical presentation and functional impacts of ADHD in adults vary greatly from their child and adolescent counterparts. Here: latest information on this complex topic.

A reminder that success in life requires paying attention to the basics, starting with showing up and hanging in there.

I want my patients to believe I consider Peabody’s advice before I see them, that I recognize our shared humanity...

Striking findings on the relationship between stress and depression.

Flibanserin is a breakthrough. We will finally be able to talk to women with hypoactive sexual desire disorder about a treatment that has FDA approval.